The researchers identified a phenomenon called GLP-1 resistance, in which the body produces higher levels of the hormone GLP-1 (glucagon-like peptide-1) but fails to respond to it properly
A commonly reported figure is one in 30,000 people in the world, according to studies conducted before researchers discovered its genetic causeany one of a number of possible mutations in the bodys ATP7B gene, which is involved in transporting copper in the body
Get a personalized supplement routine in 60 seconds.
Yang YS, Su YF, Yang HW, Lee YH, Chou JI, Ueng KC
Retatrutide is not yet commercially available, meaning current pricing reflects the grey market peptide landscape rather than pharmaceutical pricing
BioSpace / Novo Nordisk corporate release (2026) 9